Pancreatic Cancer Research

ResearcherYonsei UniversityActive in the last 2 years

Jaekyoung Son

Matched on ORCID iD 0000-0001-8152-9210; OpenAlex author ID A5069785427, A5108297871. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
29
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: 2 papers · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 10

  1. BIX01294 suppresses PDAC growth through inhibition of glutaminase-mediated glutathione dynamics. Last author DOI 10.1016/j.molmet.2025.102113↗
  2. Glutamine-mediated epigenetic regulation of cFLIP underlies resistance to TRAIL in pancreatic cancer. Last author DOI 10.1038/s12276-024-01231-0↗
  3. Suppression of fatty acid oxidation supports pancreatic cancer growth and survival under hypoxic conditions through autophagy induction. Co-author DOI 10.1038/s41417-023-00598-y↗
  4. TFEB Supports Pancreatic Cancer Growth through the Transcriptional Regulation of Glutaminase. Last author DOI 10.3390/cancers13030483↗
  5. Overall survival of pancreatic ductal adenocarcinoma is doubled by Aldh7a1 deletion in the KPC mouse. Co-author DOI 10.7150/thno.53935↗
  6. Branched-chain amino acids sustain pancreatic cancer growth by regulating lipid metabolism. Last author DOI 10.1038/s12276-019-0350-z↗
  7. Matrine suppresses KRAS-driven pancreatic cancer growth by inhibiting autophagy-mediated energy metabolism. Last author DOI 10.1002/1878-0261.12324↗
  8. Quercetin sensitizes pancreatic cancer cells to TRAIL-induced apoptosis through JNK-mediated cFLIP turnover. Last author DOI 10.1016/j.biocel.2016.07.033↗
  9. Autophagy is required for PDAC glutamine metabolism. Last author DOI 10.1038/srep37594↗
  10. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Co-author DOI 10.1038/nature12040↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ji Hye Kim · 6 shared papers, 2016–2024 · strength 0.79
  2. Se Seul Im · 2 shared papers, 2024–2025 · strength 0.46
  3. Kyung‐Chul Choi · 3 shared papers, 2016–2024 · strength 0.43
  4. Young-Ra Cho · 3 shared papers, 2018–2021 · strength 0.32
  5. Boyun Kim · 1 shared paper, 2024 · strength 0.20
  6. Eun‐Ju Chang · 1 shared paper, 2024 · strength 0.20
  7. Seungyeon Yang · 1 shared paper, 2023 · strength 0.18
  8. Seung Min Jeong · 1 shared paper, 2023 · strength 0.18
  9. Byung-Joo Kim · 1 shared paper, 2023 · strength 0.18
  10. Ji Hyeon Lee · 2 shared papers, 2018–2019 · strength 0.18
  11. Jae-Seon Lee · 1 shared paper, 2021 · strength 0.12
  12. Eun Kyung Hong · 1 shared paper, 2021 · strength 0.12
  13. Sung‐Sik Han · 1 shared paper, 2021 · strength 0.12
  14. Soo‐Youl Kim · 1 shared paper, 2021 · strength 0.12
  15. Hyonchol Jang · 1 shared paper, 2021 · strength 0.12
  16. Sang Myung Woo · 1 shared paper, 2021 · strength 0.12
  17. Juwon Seo · 1 shared paper, 2016 · strength 0.06
  18. Heesun Cheong · 1 shared paper, 2016 · strength 0.06
  19. Lewis C. Cantley · 1 shared paper, 2013 · strength 0.03
  20. Ya’an Kang · 1 shared paper, 2013 · strength 0.03
  21. Cristina R. Ferrone · 1 shared paper, 2013 · strength 0.03
  22. Matteo Ligorio · 1 shared paper, 2013 · strength 0.03
  23. Haoqiang Ying · 1 shared paper, 2013 · strength 0.03
  24. Ronald Anthony Depinho · 1 shared paper, 2013 · strength 0.03
  25. Alec C. Kimmelman · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.